HIIT, Cardiorespiratory Fitness, and Metabolic Health in Healthy Young Adults
High-intensity Interval Training Improves Cardiorespiratory Fitness and Modestly Enhances Metabolic Health in Healthy Young Adults : a Randomized Controlled Trial
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
Tipo de estudio
Tipo de estudio
Inscripción (Actual)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Boulifa
-
El Kef, Boulifa, Túnez, 7100
- Tunisia
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Male university students at the High Institute of Sport and Physical Education, Kef, Tunisia.
- Aged 19 to 25 years
- Provided written informed consent
Exclusion Criteria:
- Acute or chronic disease contraindicating vigorous physical exercise
- Musculoskeletal injury or any other medical condition limiting participation in exercise
- Participation in another structured training program within the previous 6 months
- Current or recent (within the previous 3 months) use of medications or dietary supplements that could influence the study outcomes
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Sin intervención: Grupo de control
Los participantes en el grupo de control mantuvieron sus actividades diarias normales.
|
|
|
Experimental: High-intensity interval training (HIIT) group
The HIIT group performed a HIIT program consisting of three sessions per week for 9 weeks, including three sets of six to eight bouts of 30-second runs at high intensity [100-110% of maximal aerobic speed (MAS)], interspersed with 30-second recovery runs at low intensity (50% MAS) between bouts, in line with recommendations by Ouerghi et al. (2017, 2026) in young males.
|
The HIIT program consisted of three sessions per week for 9 weeks, comprising of three sets of sixr to eight bouts of 30-second runs at high intensity [100-110% of maximal aerobic speed (MAS)], interspersed with 30-second recovery runs at low intensity (50% MAS) between bouts.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Insulin resistance
Periodo de tiempo: One day before the start and two days after the completion of the 09 weeks of training program.
|
Insulin resistance was estimated by the homeostasis model assessment (HOMA-IR) index as HOMA-IR = (fasting insulin (mU/l) × fasting glucose (mmol/l) / 22.5)) (Matthews et al., 1985).
|
One day before the start and two days after the completion of the 09 weeks of training program.
|
|
Total cholesterol
Periodo de tiempo: One day before the start and two days after the completion of the 09 weeks of training program.
|
Total cholesterol concentration, expressed in mg/dL, was assessed by the enzymatic method on an Architect C8000 auto analyzer (Abbott Laboratories, Abbott Park, IL) using respective reagent kits.
|
One day before the start and two days after the completion of the 09 weeks of training program.
|
|
Triglyceride
Periodo de tiempo: One day before the start and two days after the completion of the 09 weeks of training program.
|
Triglyceride concentration, expressed in mg/dL, was assessed by the enzymatic method on an Architect C8000 auto analyzer (Abbott Laboratories, Abbott Park, IL) using respective reagent kits.
|
One day before the start and two days after the completion of the 09 weeks of training program.
|
|
Blood pressure
Periodo de tiempo: One day before the start and two days after the completion of the 09 weeks of training program
|
Blood pressure, expressed in mmHg, was measured after 15 minutes of seated rest using an automatic blood pressure monitor (Omron BP652; Omron Healthcare Inc., Vernon Hills, IL, USA).
|
One day before the start and two days after the completion of the 09 weeks of training program
|
|
Cardiorespiratory fitness
Periodo de tiempo: One day before the start and two days after the completion of the 09 weeks of training program.
|
Cardiorespiratory fitness was assessed using the Vameval incremental running test performed to exhaustion (Cazorla, 1999).
Maximal aerobic speed (MAS) was determined from the highest running speed achieved during the test, and maximal oxygen consumption (VO2max) was estimated using the standard Vameval protocol (Cazorla, 1999).
The Vameval test is a validated field test for assessing aerobic capacity in healthy young adults.
|
One day before the start and two days after the completion of the 09 weeks of training program.
|
|
Body mass index
Periodo de tiempo: One day before the start and two days after the completion of the 09 weeks of training program
|
Body mass index (BMI), expressed in kg/m², was calculated from measured body mass (kg) and height (m) using the standard formula: BMI = body mass (kg) / height² (m²).
Body mass and height were used only to derive BMI and were not considered separate outcome measures.
|
One day before the start and two days after the completion of the 09 weeks of training program
|
|
Body fat percentage
Periodo de tiempo: One day before the start and two days after the completion of the 09 weeks of training program.
|
Body fat percentage (%) was estimated from four skinfold measurements (bicipital, triceps, subscapular, and suprailiac) using the Durnin and Womersley (1973) method.
|
One day before the start and two days after the completion of the 09 weeks of training program.
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Fasting glucose
Periodo de tiempo: One day before the start and two days after the completion of the 09 weeks of training program.
|
Fasting glucose concentration, expressed in mg/dL, was assessed by the enzymatic method on an Architect C8000 auto analyzer (Abbott Laboratories, Abbott Park, IL) using respective reagent kits.
|
One day before the start and two days after the completion of the 09 weeks of training program.
|
|
Insulin
Periodo de tiempo: One day before the start and two days after the completion of the 09 weeks of training program.
|
Insulin concentration, expressed in µU/mL, was measured by chemiluminescence immunoassay using a Liaison analyzer and the respective reagents kit (DiaSorin Inc., Stillwater, MN, USA).
|
One day before the start and two days after the completion of the 09 weeks of training program.
|
|
High-density lipoprotein cholesterol
Periodo de tiempo: One day before the start and two days after the completion of the 09 weeks of training program.
|
High-density lipoprotein cholesterol, expressed in mg/dL, was assessed by the enzymatic method on an Architect C8000 auto analyzer (Abbott Laboratories, Abbott Park, IL) using respective reagent kits.
|
One day before the start and two days after the completion of the 09 weeks of training program.
|
|
Low-density lipoprotein cholesterol
Periodo de tiempo: One day before the start and two days after the completion of the 09 weeks of training program
|
Low-density lipoprotein cholesterol, expressed in mg/dL, was calculated using the Friedewald formula (Friedewald et al., 1972).
|
One day before the start and two days after the completion of the 09 weeks of training program
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Nejmeddine Ouerghi, Ph.D, Research Unit "Sport Sciences, Health and Movement"(UR22JS01) High Institute of Sport and Physical Education of Kef, University of Jendouba, 7100 Kef, Tunisia.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Actual)
Finalización primaria
Finalización del estudio (Actual)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Enfermedades metabólicas
- Trastornos del metabolismo de la glucosa
- Hiperinsulinismo
- Enfermedades Nutricionales y Metabólicas
- Resistencia a la insulina
- Actividad motora
- Movimiento
- Fenómenos fisiológicos musculoesqueléticos
- Fenómenos fisiológicos musculoesqueléticos y neuronales
- Acondicionamiento físico, humano
- Ejercicio
- Entrenamiento de intervalos de alta intensidad
Otros números de identificación del estudio
Otros números de identificación del estudio
- HIIT-MET-STUDENTS
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .